Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes

References

• Morrissey JH, Mutch NJ. Tissue factor structure and function. In: , Colman R W, Marder V J, Clowes A W, George J N, Goldhaber S Z, editors. Hemostasis, thrombosis. 5th, ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. p. 91–106.
   Google Scholar
• Rao LV, Robinson T, Hoang AD. Factor VIIa/tissue factor-catalyzed activation of factors IX and X on a cell surface and in suspension: a kinetic study. Thromb Haemost 1992;67:654–9.
   PubMed Web of Science ®Google Scholar
• Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993;81:734–44.
   PubMed Web of Science ®Google Scholar
• Morrissey JH. Plasma factor VIIa: measurement and potential clinical significance. Haemostasis 1996;26(Suppl. 1):66–71.
   PubMedGoogle Scholar
• Hellstern P, Beeck H, Fellhauer A, Fischer A, Faller-Stöckl B. Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates. Thromb Res 1997;86:493–504.
   PubMed Web of Science ®Google Scholar
• Lippi G, Montagnana M, Salvagno GL, Poli G, Franchini M, Guidi GC. Influence of warfarin therapy on activated factor VII clotting activity. Blood Coagul Fibrinolysis 2006;17:221–4.
   PubMed Web of Science ®Google Scholar
• Yamada A, Wada H, Kamikura Y, Hiyoyama K, Shimura M, Nagaya S, et al.. Plasma levels of activated FVII in various diseases. Blood Coagul Fibrinolysis 1996;7:794–8.
   PubMed Web of Science ®Google Scholar
• Bourgeat P, Jasmin P, Migaud-Fressart M, Martinoli JL. Direct measurement of activated factor VII in plasma: development of an original assay. Thromb Haemostas 1995;73:1204.
   Web of Science ®Google Scholar
• Perry DJ. Factor VII deficiency. Br J Haematol 2002;118:689–700.
   PubMed Web of Science ®Google Scholar
• Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A. Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978;91:387–95.
   PubMed Web of Science ®Google Scholar
• Girolami A, Sartori MT, Steffan A, Fadin MA. Recombinant thromboplastin is slightly more sensitive to factor VII Padua than standard thromboplastins of human origin. Blood Coagul Fibrinolysis 1993;4:497–8.
   PubMed Web of Science ®Google Scholar
• Girolami A, Patrassi G, Cappellato G, Casonato A. Another family with the factor VII Padua clotting defect. Acta Haematol 1979;62:4–11.
   Web of Science ®Google Scholar
• Girolami A, Dal Bo Zanon R, Zanella F, Procidano M, Ruffato G. Factor VII Padua defect: the heterozygote population. Acta Haematol 1982;68:34–8.
   PubMed Web of Science ®Google Scholar
• Girolami A, de Marinis GB, Bonamigo E, Allemand E. Worldwide diffusion of FVII Arg304Gln in coagulation defect (FVII Padua). Eur J Haematol 2011;86:135–9.
   PubMed Web of Science ®Google Scholar
• Saito M, Asakura H, Yoshida T, Jokaji H, Uotani C, Kumabashiri I, et al.. Levels of activated factor VII in patients with disseminated intravascular coagulation. Blood 1995;85:3770–1.
   PubMed Web of Science ®Google Scholar
• Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993;342:1076–9.
   PubMed Web of Science ®Google Scholar
• Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP, Meade TW. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1985;59:249–58.
   PubMed Web of Science ®Google Scholar
• Cid AR, Lorenzo JI, Haya S, Montoro JM, Casaña P, Aznar JA. A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment. Haemophilia 2001;7:39–41.
   PubMed Web of Science ®Google Scholar
• Croom KF, McCormack PL. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders. BioDrugs 2008;22:121–36.
   PubMed Web of Science ®Google Scholar
• Klitgaard T, Nielsen TG. Overview of the human pharmacokinetics of recombinant activated factor VII. Br J Clin Pharmacol 2008;65:3–11.
   PubMed Web of Science ®Google Scholar
• Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, et al.. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII. Arterioscler Thromb Vasc Biol 1996;16:1170–6.
   PubMed Web of Science ®Google Scholar
• Scharling B, Nielsen GG, Klitgaard T, Skovsted TA, Møss J, Segel S, et al.. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma. Blood Coagul Fibrinolysis 2007;18:677–84.
   PubMed Web of Science ®Google Scholar
• Kario K, Matsuo T, Asada R, Sakata T, Kato H, Miyata T. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level. Thromb Haemost 1995;73:429–34.
   PubMed Web of Science ®Google Scholar
• Kitchen S, Malia RG, Preston FE. A comparison of methods for the measurement of activated factor VII. Thromb Haemost 1992;68:301–5.
   PubMed Web of Science ®Google Scholar
• Shurafa MS, Kumar A, Fair DS, James HL. The molecular defect in FVII (Detroit) is due to substitution of Arg(304) by Glu. FASEB J 1993;17:115 (abstract).
   Google Scholar
• Sabharwal AK, Kuppuswamy MN, Foster DC, Wildgoose P, Fisher L, Birktoft JJ, et al.. Factor VII deficiency (F VII Richmond, R304Q mutant) associated with thrombosis. Circulation 1992;86(Suppl.):679 (abstract).
   Google Scholar
• Etro D, Pinotti M, Wulff K, Marchetti G, Rocino A, Herrmann FH, et al.. The Gly331Ser mutation in factor VII in Europe and the Middle East. Haematologica 2003;88:1434–6.
   PubMed Web of Science ®Google Scholar
• Wulff K, Herrmann FH. Twenty two novel mutations of the factor VII gene in factor VII deficiency. Hum Mutat 2000;15:489–96.
   PubMed Web of Science ®Google Scholar
• Marty S, Barro C, Chatelain B, Fimbel B, Tribout B, Reynaud J, et al.. The paradoxical association between inherited factor VII deficiency and venous thrombosis. Haemophilia 2008;14:564–70.
   PubMed Web of Science ®Google Scholar
• Triplett DA, Brandt JT, Batard MA, Dixon JL, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985;66:1284–7.
   PubMed Web of Science ®Google Scholar
• Girolami A, Tezza F, Scandellari R, Vettore S, Girolami B. Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature. J Thromb Thrombolysis 2010;30:172–8.
   PubMed Web of Science ®Google Scholar